Frontlight ResearchEarly access
Trial site
Jilin Cancer Hospital
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Ovarian cancer1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Phase 1/21 trial
- Status
- Completed2 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Allist Pharmaceuticals, Inc.1 trial
- Dizal Pharmaceuticals1 trial
- Impact Therapeutics, Inc.1 trial
- Laekna Limited1 trial
- Shanghai Junshi Bioscience Co., Ltd.1 trial
- and 1 more
Running trials
Recruiting
SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
Closed trials
Terminated
Completed
Completed
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian
Site data: ClinicalTrials.govUpdated 12 Nov 2026